Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Thompson

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2006
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancerGustavo Ayala, Takefumi Satoh, Rile Li, et al.
Urologic Oncology|February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer modelsTetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate CancerZhe Tang, Patrick G Pilié, Chuandong Geng, et al.
The Journal of Urology|September 28, 2002
The role of caveolin-1 in androgen insensitive prostate cancerVladimir Mouraviev, Likun Li, Salahaldin A Tahir, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2002
Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer modelMaria T Vlachaki, Andres Hernandez-Garcia, Michael Ittmann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 21, 2015
Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort StudyJianhua Yin, Junxue Wang, Rui Pu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersAna M Aparicio, Li Shen, Elsa Li Ning Tapia, et al.
Cell Reports|May 11, 2022
The lactate-NAD<sup>+</sup> axis activates cancer-associated fibroblasts by downregulating p62Juan F Linares, Tania Cid-Diaz, Angeles Duran, et al.
Biomedical and Environmental Sciences : BES|September 27, 2014
Environmental and psycho-social factors related to prostate cancer risk in the Chinese population: a case-control studyMei Ling Li, Ji Lin, Jian Guo Hou, et al.
International Journal of Cancer|December 27, 2017
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer modelsYong Luo, Abul Kalam Azad, Styliani Karanika, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2006
Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancerGustavo Ayala, Takefumi Satoh, Rile Li, et al.
Urologic Oncology|February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer modelsTetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate CancerZhe Tang, Patrick G Pilié, Chuandong Geng, et al.
The Journal of Urology|September 28, 2002
The role of caveolin-1 in androgen insensitive prostate cancerVladimir Mouraviev, Likun Li, Salahaldin A Tahir, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2002
Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer modelMaria T Vlachaki, Andres Hernandez-Garcia, Michael Ittmann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 21, 2015
Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort StudyJianhua Yin, Junxue Wang, Rui Pu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate CancersAna M Aparicio, Li Shen, Elsa Li Ning Tapia, et al.
Cell Reports|May 11, 2022
The lactate-NAD<sup>+</sup> axis activates cancer-associated fibroblasts by downregulating p62Juan F Linares, Tania Cid-Diaz, Angeles Duran, et al.
Biomedical and Environmental Sciences : BES|September 27, 2014
Environmental and psycho-social factors related to prostate cancer risk in the Chinese population: a case-control studyMei Ling Li, Ji Lin, Jian Guo Hou, et al.
International Journal of Cancer|December 27, 2017
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer modelsYong Luo, Abul Kalam Azad, Styliani Karanika, et al.
Pageof 12